These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 13154892)

  • 21. Experimental study on the vitreous; II. Experiments on disappearance of red blood cells from the vitreous effects of hyaluronidase; effect of short bouts of artificial fever and changes in the basic metabolic rate.
    SALLMANN L
    Arch Ophthal; 1950 Apr; 43(4):638-52. PubMed ID: 15411288
    [No Abstract]   [Full Text] [Related]  

  • 22. Experimental liquefaction of the vitreous body.
    Skrzypczak-Spak KE; Dresden MH
    Ann Ophthalmol; 1971 Jun; 3(6):624-30 p. PubMed ID: 4366359
    [No Abstract]   [Full Text] [Related]  

  • 23. Safety results of two phase III trials of an intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage.
    Kuppermann BD; Thomas EL; de Smet MD; Grillone LR;
    Am J Ophthalmol; 2005 Oct; 140(4):585-97. PubMed ID: 16226510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental retinal detachment.
    Agarwal LP; Dhiri S; Khosla PK; Sirivastva OP
    Bibl Ophthalmol; 1969; 79():106-10. PubMed ID: 4242198
    [No Abstract]   [Full Text] [Related]  

  • 25. [Method of determining the colloidal status of the vitreous body].
    Agafonov VA; Anisimov SI; Fedorov SN
    Biull Eksp Biol Med; 1984 Dec; 98(12):761-4. PubMed ID: 6095956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The safety of intravitreal hyaluronidase. A clinical and histologic study.
    Gottlieb JL; Antoszyk AN; Hatchell DL; Saloupis P
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2345-52. PubMed ID: 2242999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of hyaluronidase injection on the vitreous humour of the rabbit.
    PIRIE A
    Br J Ophthalmol; 1949 Nov; 33(11):678-84. PubMed ID: 15392448
    [No Abstract]   [Full Text] [Related]  

  • 28. Pooled efficacy results from two multinational randomized controlled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage.
    Kuppermann BD; Thomas EL; de Smet MD; Grillone LR;
    Am J Ophthalmol; 2005 Oct; 140(4):573-84. PubMed ID: 16125661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enzyme-assisted vitrectomy in enucleated pig eyes: a comparison of hyaluronidase, chondroitinase, and plasmin.
    Staubach F; Nober V; Janknecht P
    Curr Eye Res; 2004; 29(4-5):261-8. PubMed ID: 15590471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of structural changes of vitreous body on the metabolism and morphokinesis of eye structures].
    Stankiewicz A; Szram S; Kulig A
    Klin Oczna; 1975 Dec; 45(12):1243-6. PubMed ID: 1214436
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacologic vitreolysis.
    Rhéaume MA; Vavvas D
    Semin Ophthalmol; 2010; 25(5-6):295-302. PubMed ID: 21091015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enzyme-induced posterior vitreous detachment in the rat produces increased lens nuclear pO2 levels.
    Giblin FJ; Quiram PA; Leverenz VR; Baker RM; Dang L; Trese MT
    Exp Eye Res; 2009 Feb; 88(2):286-92. PubMed ID: 18835558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Research on the effect of the intraspinal administration of hyaluronidase. II. Duration of spreading of hyaluronidase introduced into the spinal fluid by intraspinal administration].
    CARGNELLO D; TISCHLER A
    Sist Nerv; 1952; 4(3):214-6. PubMed ID: 12995087
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experiments on the effect of hyaluronidase on capillary walls].
    HUBNER KA; GERSING R; SCHUMACHER H
    Arztl Wochensch; 1952 Sep; 7(39):913-6. PubMed ID: 12996354
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pathological changes in the ciliary body and iris in the course of experimental depolymerization of the vitreous body in rabbits].
    Szram S; Stankiewicz A; Kulig A
    Klin Oczna; 1975 Dec; 45(12):1247-50. PubMed ID: 1214437
    [No Abstract]   [Full Text] [Related]  

  • 36. Enzymatic vitreous disruption.
    Gandorfer A
    Eye (Lond); 2008 Oct; 22(10):1273-7. PubMed ID: 18292784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Research on the effect of the intraspinal administration of hyaluronidase. I. Variations of the cerebrospinal fluid picture after intraspinal injection of hyaluronidase].
    CARGNELLO D; TISCHLER A
    Sist Nerv; 1952; 4(3):208-13. PubMed ID: 12995086
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies on the vitreous humor; further observations on sequelae and treatment of prolapsed vitreous: properties of vitreous dependent upon the hyaluronic-acid content.
    IRVINE SR; BRUNISH R; ROWEN JW
    Am J Ophthalmol; 1955 Apr; 39(4 Pt 2):100-8. PubMed ID: 14361610
    [No Abstract]   [Full Text] [Related]  

  • 39. Reversible inhibition of chondrogenic expression by certain hyaluronidase preparations.
    Pennypacker JP; Goetinck PF
    J Embryol Exp Morphol; 1979 Oct; 53():91-102. PubMed ID: 536698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pathogenetic mechanism of leukocyte changes due to the hyaluronidase tonsillar test. (Effects of the preliminary administration of neuro-depressive drugs)].
    RINALDI L
    Boll Mal Orecch Gola Naso; 1960; 78():1-31. PubMed ID: 13854522
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.